Showing results (131-140 of 537) with videos related to
Sort By:
Pageof 54
Neurologic Clinics|April 8, 2014
Headaches caused by nasal and paranasal sinus diseaseMichael J Marmura, Stephen D SilbersteinHandbook of Clinical Neurology|February 2, 2024
Evidence-based preventive treatment of migraineCallum W Duncan, Stephen D SilbersteinThe Lancet. Neurology|October 10, 2014
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trialDavid W Dodick, Peter J Goadsby, Stephen D Silberstein, et al.Cephalalgia : an International Journal of Headache|May 21, 2025
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sexFrank Porreca, Edita Navratilova, David W DodickCNS Drugs|December 28, 2006
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraineDavid W Dodick, Giorgio Sandrini, Paul WilliamsThe Laryngoscope|September 13, 2014
Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headacheDevyani Lal, Alexis Rounds, David W DodickSeminars in Neurology|March 31, 2010
Cluster headache: diagnosis and treatmentRashmi Halker, Bert Vargas, David W DodickCephalalgia : an International Journal of Headache|March 6, 2018
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adultsCristina Tassorelli, Hans-Christoph Diener, David W Dodick, et al.Clinics in Dermatology|May 26, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersDavid Dodick, Andrew Blumenfeld, Stephen D SilbersteinCurrent Opinion in Neurology|March 19, 2019
The endocannabinoid system in migraine: from bench to pharmacy and backCristina Tassorelli, Rosaria Greco, Stephen D SilbersteinPageof 54